Resolvins are potent analgesics for arthritic pain

British Journal of Pharmacology

Volumn 164, Issue 2, 2011, Pages 274-277

  Xu, Zhen Zhong ^a   Ji, Ru Rong ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

arthritis; dorsal root ganglion; inflammatory pain; lipid mediators; Resolvin; RvD1 precursor; spinal cord; TNF

Indexed keywords

17 HYDROXYDOCOSAHEXAENOIC ACID; ANALGESIC AGENT; ASPIRIN TRIGGERED RESOLVIN D1; ASPIRIN TRIGGERED RESOLVIN D2; ASPIRIN TRIGGERED RESOLVIN D3; ASPIRIN TRIGGERED RESOLVIN D4; ASPIRIN TRIGGERED RESOLVIN D5; CYCLOOXYGENASE 2 INHIBITOR; DEXAMETHASONE; FATTY ACID DERIVATIVE; GABAPENTIN; INDOMETACIN; INTERLEUKIN 1BETA; MORPHINE; NARCOTIC ANALGESIC AGENT; RESOLVIN; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA INHIBITOR; UNCLASSIFIED DRUG;

ANALGESIC ACTIVITY; ANTINOCICEPTION; ARTHRITIS; CARDIOVASCULAR DISEASE; CONSTIPATION; CYTOKINE PRODUCTION; DRUG EFFICACY; DRUG MECHANISM; DRUG POTENCY; DRUG SAFETY; DRUG TARGETING; HUMAN; HYPERALGESIA; JOINT STIFFNESS; LOW DRUG DOSE; NAUSEA; NONHUMAN; PAIN; PAW EDEMA; PRIORITY JOURNAL; RESPIRATION DEPRESSION; REVIEW; RHEUMATOID ARTHRITIS; SEDATION; SIDE EFFECT; VOMITING;

ANALGESICS; ARTHRITIS; DOCOSAHEXAENOIC ACIDS; HUMANS; MOLECULAR STRUCTURE; PAIN;

EID: 80052001049     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1111/j.1476-5381.2011.01348.x     Document Type: Review

References (14)

1. Bang S, Yoo S, Yang TJ, Cho H, Kim YG, Hwang SW, (2010). Resolvin D1 attenuates activation of sensory transient receptor potential channels leading to multiple anti-nociception. Br J Pharmacol 161: 707-720.
2. Cheng JK, Ji RR, (2008). Intracellular signaling in primary sensory neurons and persistent pain. Neurochem Res 33: 1970-1978.
3. Gilroy DW, Colville-Nash PR, Willis D, Chivers J, Paul-Clark MJ, Willoughby DA, (1999). Inducible cyclooxygenase may have anti-inflammatory properties. Nat Med 5: 698-701. (Pubitemid 29289435)
4. Hess A, Axmann R, Rech J, Finzel S, Heindl C, Kreitz S, et al,. (2011). Blockade of TNF- rapidly inhibits pain responses in the central nervous system. Proc Natl Acad Sci U S A 108: 3731-3736.
5. Huang L, Wang CF, Serhan CN, Strichartz G, (2011). Enduring prevention and transient reduction of postoperative pain by intrathecal resolvin D1. Pain 152: 557-565.
6. Kawasaki Y, Zhang L, Cheng JK, Ji RR, (2008). Cytokine mechanisms of central sensitization: distinct and overlapping role of interleukin-1beta, interleukin-6, and tumor necrosis factor-alpha in regulating synaptic and neuronal activity in the superficial spinal cord. J Neurosci 28: 5189-5194.
7. Krishnamoorthy S, Recchiuti A, Chiang N, Yacoubian S, Lee CH, Yang R, et al,. (2010). Resolvin D1 binds human phagocytes with evidence for proresolving receptors. Proc Natl Acad Sci U S A 107: 1660-1665.
8. Lima-Garcia JF, Dutra RC, da Silva KABS, Motta EM, Campos MM, Calixto JB, (2011). The precursor of resolvin D series and aspirin-triggered resolvin D1 display anti-hyperalgesic properties in adjuvant-induced arthritis in rats. Br J Pharmacol 164: 278-293.
9. Samad TA, Moore KA, Sapirstein A, Billet S, Allchorne A, Poole S, et al,. (2001). Interleukin-1beta-mediated induction of Cox-2 in the CNS contributes to inflammatory pain hypersensitivity. Nature 410: 471-475. (Pubitemid 32240046)
10. Serhan CN, (2007). Resolution phase of inflammation: novel endogenous anti-inflammatory and proresolving lipid mediators and pathways. Annu Rev Immunol 25: 101-137. (Pubitemid 46697904)
11. Serhan CN, Hong S, Gronert K, Colgan SP, Devchand PR, Mirick G, et al,. (2002). Resolvins: a family of bioactive products of omega-3 fatty acid transformation circuits initiated by aspirin treatment that counter proinflammation signals. J Exp Med 196: 1025-1037. (Pubitemid 35231761)
12. Serhan CN, Chiang N, Van Dyke TE, (2008). Resolving inflammation: dual anti-inflammatory and pro-resolution lipid mediators. Nat Rev Immunol 8: 349-361. (Pubitemid 351595216)
13. Sommer C, Birklein F, (2010). Fighting off pain with resolvins. Nat Med 16: 518-520.
14. Xu ZZ, Zhang L, Liu T, Park JY, Berta T, Yang R, et al,. (2010). Resolvins RvE1 and RvD1 attenuate inflammatory pain via central and peripheral actions. Nat Med 16: 592-597.